148 related articles for article (PubMed ID: 2015217)
21. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
Mousli M; Hugli TE; Landry Y; Bronner C
J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
[TBL] [Abstract][Full Text] [Related]
22. Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.
Sun J; Ember JA; Chao TH; Fukuoka Y; Ye RD; Hugli TE
Protein Sci; 1999 Nov; 8(11):2304-11. PubMed ID: 10595533
[TBL] [Abstract][Full Text] [Related]
23. The primary structure of porcine C3a anaphylatoxin.
Corbin NC; Hugli TE
J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
25. Peptide analogues of the anaphylatoxin C3a; syntheses and properties.
Ambrosius D; Casaretto M; Gerardy-Schahn R; Saunders D; Brandenburg D; Zahn H
Biol Chem Hoppe Seyler; 1989 Mar; 370(3):217-27. PubMed ID: 2713103
[TBL] [Abstract][Full Text] [Related]
26. Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin.
Gao J; Choe H; Bota D; Wright PL; Gerard C; Gerard NP
J Biol Chem; 2003 Sep; 278(39):37902-8. PubMed ID: 12871936
[TBL] [Abstract][Full Text] [Related]
27. Cyclic disulfide analogues of the complement component C3a. Synthesis and conformational investigations.
Pohl M; Ambrosius D; Grötzinger J; Kretzschmar T; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D; Höcker H
Int J Pept Protein Res; 1993 Apr; 41(4):362-75. PubMed ID: 8496018
[TBL] [Abstract][Full Text] [Related]
28. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
29. Evidence that the receptor for C4a is distinct from the C3a receptor.
Ames RS; Tornetta MA; Foley JJ; Hugli TE; Sarau HM
Immunopharmacology; 1997 Dec; 38(1-2):87-92. PubMed ID: 9476119
[TBL] [Abstract][Full Text] [Related]
30. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach.
Pasupuleti M; Walse B; Svensson B; Malmsten M; Schmidtchen A
Biochemistry; 2008 Sep; 47(35):9057-70. PubMed ID: 18690701
[TBL] [Abstract][Full Text] [Related]
31. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
Huey R; Erickson BW; Bloor CM; Hugli TE
Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
[TBL] [Abstract][Full Text] [Related]
32. Complement factors and their receptors.
Ember JA; Hugli TE
Immunopharmacology; 1997 Dec; 38(1-2):3-15. PubMed ID: 9476110
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
[TBL] [Abstract][Full Text] [Related]
34. Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.
Gerardy-Schahn R; Ambrosius D; Casaretto M; Grötzinger J; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D
Biochem J; 1988 Oct; 255(1):209-16. PubMed ID: 3264156
[TBL] [Abstract][Full Text] [Related]
35. Human anaphylatoxin (C3a) from the third component of complement. Primary structure.
Hugli TE
J Biol Chem; 1975 Nov; 250(21):8293-301. PubMed ID: 1238393
[TBL] [Abstract][Full Text] [Related]
36. Cellular receptors to the anaphylatoxins C3a and C5a.
Huey R; Fukuoka Y; Hoeprich PD; Hugli TE
Biochem Soc Symp; 1986; 51():69-81. PubMed ID: 3545212
[TBL] [Abstract][Full Text] [Related]
37. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
38. Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study.
Federwisch M; Casaretto M; Gerardy-Schahn R; Bitter-Suermann D; Wollmer A
Biophys Chem; 1992 Oct; 44(3):151-61. PubMed ID: 1420945
[TBL] [Abstract][Full Text] [Related]
39. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L; Carney DF; Hugli TE
Protein Sci; 1994 Aug; 3(8):1169-77. PubMed ID: 7987212
[TBL] [Abstract][Full Text] [Related]
40. Selective hexapeptide agonists and antagonists for human complement C3a receptor.
Scully CC; Blakeney JS; Singh R; Hoang HN; Abbenante G; Reid RC; Fairlie DP
J Med Chem; 2010 Jul; 53(13):4938-48. PubMed ID: 20527893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
